8.98
-0.12(-1.32%)
Currency In USD
| Previous Close | 9.1 |
| Open | 8.77 |
| Day High | 9.01 |
| Day Low | 8.7 |
| 52-Week High | 6,241.05 |
| 52-Week Low | 7.26 |
| Volume | 18,004 |
| Average Volume | 214,446 |
| Market Cap | 9.12M |
| PE | 0 |
| EPS | -6,111.44 |
| Moving Average 50 Days | 59.85 |
| Moving Average 200 Days | 1,282.34 |
| Change | -0.12 |
If you invested $1000 in Aclarion, Inc. (ACON) since IPO date, it would be worth $0.02 as of April 19, 2025 at a share price of $8.98. Whereas If you bought $1000 worth of Aclarion, Inc. (ACON) shares 2 years ago, it would be worth $0.08 as of April 19, 2025 at a share price of $8.98.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Aclarion to Present at the Planet MicroCap Showcase: VEGAS in Partnership with MicroCapClub
GlobeNewswire Inc.
Apr 09, 2025 11:00 AM GMT
Wednesday, April 23, 2025 & 1x1 Meetings on Thursday, April 24, 2025BROOMFIELD, Colo., April 09, 2025 (GLOBE NEWSWIRE) -- Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomar
Aclarion Announces Expansion to Santa Monica with Medical Imaging Center of Southern California
GlobeNewswire Inc.
Apr 02, 2025 10:00 AM GMT
MICSC are leaders in Los Angeles providing MRI and Diagnostic Imaging services MICSC expands access to Nociscan beyond Beverly Hills now available in Santa Monica BROOMFIELD, Colo., April 02, 2025 (GLOBE NEWSWIRE) -- Aclarion, Inc., (“Aclarion” or
Aclarion Provides Update on Strength of Company Positioning Following Q1 Strategic Initiatives
GlobeNewswire Inc.
Mar 31, 2025 11:00 AM GMT
Over $20M raised in Q1 with nearly $15M cash on hand No debt, no preferred equity, and no warrants with strike prices near the current market Nasdaq compliant: fully meets bid price and shareholder equity requirements Pivotal CLARITY trial fully fun
Data not available